Precision Biosciences (DTIL) Goodwill & Intangibles (2018 - 2026)
Precision Biosciences (DTIL) reported Goodwill & Intangibles of $1.1 million for Q1 2026, up 85.67% year-over-year from $607000.0 in Q1 2025, and down 3.34% quarter-over-quarter from $1.2 million in Q4 2025.
Precision Biosciences (DTIL) Goodwill & Intangibles (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Goodwill & Intangibles data on file, last reported at $1.1 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $1.1 million, up 85.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 85.67% YoY), and the FY2025 annual result was $1.2 million, up 87.46% from the prior year.
- Goodwill & Intangibles eased to $1.1 million in Q1 2026 per DTIL's latest filing, from $1.2 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $2.0 million in Q1 2022 and troughed at $375000.0 in Q2 2024.
- A 5-year average of $1.0 million and a median of $977000.0 in 2023 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles tumbled 75.84% in 2024, then jumped 153.87% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $731000.0 in 2022, then sank by 45.28% to $400000.0 in 2023, then surged by 55.5% to $622000.0 in 2024, then soared by 87.46% to $1.2 million in 2025, then decreased by 3.34% to $1.1 million in 2026.
- Business Quant data shows DTIL's Goodwill & Intangibles at $1.1 million in Q1 2026, $1.2 million in Q4 2025, and $985000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 985,000.00 |
| Jun 30, 2025 | 605,000.00 |
| Mar 31, 2025 | 607,000.00 |
| Dec 31, 2024 | 622,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 375,000.00 |
| Mar 31, 2024 | 386,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 977,000.00 |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 731,000.00 |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.02 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | 1.34 Mn |